Some of them found that elevated CRP on admission for patients with COVID-19 was associated with increased in-patient mortality and was indicative of disease severity at admission [26–28], while other studies documented no significant differences in the CRP level among mild, severe, and critical patients. The gene discussed is CRP; the disease is COVID-19.